Sequence-specific enhancer binding protein is responsible for the differential expression of ERT/ESX/ELF-3/ESE-1/jen gene in human gastric cancer cell lines: Implication for the loss of TGF-beta type II receptor expression
- PMID: 11313868
- DOI: 10.1038/sj.onc.1204227
Sequence-specific enhancer binding protein is responsible for the differential expression of ERT/ESX/ELF-3/ESE-1/jen gene in human gastric cancer cell lines: Implication for the loss of TGF-beta type II receptor expression
Abstract
Transcriptional repression of the TGF-beta type II receptor (RII) is one of the mechanisms leading to TGF-beta resistance. The newly identified epithelium-specific ets transcription factor ERT/ESX/ELF-3/ESE-1/jen binds to the TGF-beta RII promoter and induces promoter activity. The human gastric cancer cell lines, which show undetectable level of TGF-beta RII mRNA, do not express ERT mRNA. To study the molecular mechanisms of loss of ERT expression, we have cloned and characterized the human ERT promoter. DNA transfection experiments and electrophoretic mobility shift assays have revealed the existence of a distinct enhancer element (-186 to -177) which we named ESE (ERT promoter specific element). Deletion of the ESE markedly decreased expression of the target gene. ESE interacts with two distinct nuclear protein complexes, at least one of which appears to be inactivated in a cell line which does not express the ERT mRNA, compared to a cell line expressing the ERT mRNA. These results suggest the possibility that inactivation of the sequence-specific DNA binding protein to the region from -186 to -177 contributes to the loss of ERT expression, leading to the loss of TGF-beta type II receptor mRNA in human gastric cancer cell lines.
Similar articles
-
Effect of ets-related transcription factor (ERT) on transforming growth factor (TGF)-beta type II receptor gene expression in human cancer cell lines.J Exp Clin Cancer Res. 2003 Sep;22(3):477-80. J Exp Clin Cancer Res. 2003. PMID: 14582709
-
Over-expression of ERT(ESX/ESE-1/ELF3), an ets-related transcription factor, induces endogenous TGF-beta type II receptor expression and restores the TGF-beta signaling pathway in Hs578t human breast cancer cells.Oncogene. 2000 Jan 6;19(1):151-4. doi: 10.1038/sj.onc.1203252. Oncogene. 2000. PMID: 10644990
-
Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein.Nat Genet. 1999 Oct;23(2):222-7. doi: 10.1038/13854. Nat Genet. 1999. PMID: 10508522
-
Mechanism of induction of transforming growth factor-beta type II receptor gene expression by v-Src in murine myeloid cells.Cell Growth Differ. 2001 Jan;12(1):9-18. Cell Growth Differ. 2001. PMID: 11205746
-
Truncation of the TGF-beta type II receptor gene results in insensitivity to TGF-beta in human gastric cancer cells.Oncogene. 1999 Apr 1;18(13):2213-9. doi: 10.1038/sj.onc.1202535. Oncogene. 1999. PMID: 10327067
Cited by
-
Involvement of Elf3 on Smad3 activation-dependent injuries in podocytes and excretion of urinary exosome in diabetic nephropathy.PLoS One. 2019 May 31;14(5):e0216788. doi: 10.1371/journal.pone.0216788. eCollection 2019. PLoS One. 2019. PMID: 31150422 Free PMC article.
-
Transcriptome profiling of cancer tissues in Chinese patients with gastric cancer by high-throughput sequencing.Oncol Lett. 2018 Feb;15(2):2057-2064. doi: 10.3892/ol.2017.7548. Epub 2017 Dec 8. Oncol Lett. 2018. PMID: 29434905 Free PMC article.
-
Moonlighting proteins in cancer.Cancer Lett. 2016 Jan 1;370(1):108-16. doi: 10.1016/j.canlet.2015.09.022. Epub 2015 Oct 20. Cancer Lett. 2016. PMID: 26499805 Free PMC article. Review.
-
Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer.Nat Genet. 2014 Jun;46(6):573-82. doi: 10.1038/ng.2983. Epub 2014 May 11. Nat Genet. 2014. PMID: 24816253
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
